{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/28/3302886/0/en/Entera-s-EB613-First-in-Class-Oral-PTH-1-34-Anabolic-for-Osteoporosis-Single-Tablet-Data-Selected-for-Late-Breaking-Oral-Presentation-at-ENDO-2026-Annual-Meeting-Additional-Oral-Pe.html", "message": "News view counter 763610 successfully enlarged"}